Breast epithelioid hemangioma
disease diseaseOn this page
Also known as breast histiocytoid hemangiomaepithelioid breast hemangiomaepithelioid hemangioma of breastepithelioid hemangioma of the breasthistiocytoid breast hemangiomahistiocytoid hemangioma of breasthistiocytoid hemangioma of the breast
Summary
Breast epithelioid hemangioma (MONDO:0003897) is a disease. A subtype of breast hemangioma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | breast epithelioid hemangioma |
| Mondo ID | MONDO:0003897 |
| DOID | DOID:6492 |
| NCIT | C5211 |
| UMLS | C1332627 |
| MedGen | 231965 |
| GARD | 0027046 |
| Anatomy (UBERON) | UBERON:0000310 |
| Is cancer (heuristic) | no |
Also known as: breast epithelioid hemangioma · breast histiocytoid hemangioma · epithelioid breast hemangioma · epithelioid hemangioma of breast · epithelioid hemangioma of the breast · histiocytoid breast hemangioma · histiocytoid hemangioma of breast · histiocytoid hemangioma of the breast
Disease family
This is a subtype of breast hemangioma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › benign neoplasm › thoracic benign neoplasm › breast benign neoplasm › breast hemangioma › breast epithelioid hemangioma
Related subtypes (1): breast capillary hemangioma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.